Home
RVTY
RVTY News

Latest Revvity Inc. (RVTY) News on January 22, 2025

Argus Research

7 days ago

RVTY: Raising target price to $127.00

RVTY Stock Falls Despite FDA Nod for Automated Testosterone Test

Zacks

9 days ago

RVTY Stock Falls Despite FDA Nod for Automated Testosterone Test

Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing

Business Wire

9 days ago

Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing

Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance

Business Wire

9 days ago

Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance

Revvity wins FDA clearance for ChLIA assay in free testosterone measurement

Medical Device Network

12 days ago

Revvity wins FDA clearance for ChLIA assay in free testosterone measurement

MT Newswires

12 days ago

Revvity Secures FDA Clearance for Automated Free Testosterone Test

Revvity Announces FDA Clearance for First Automated Free Testosterone Test

Business Wire

12 days ago

Revvity Announces FDA Clearance for First Automated Free Testosterone Test

MT Newswires

12 days ago

Bernstein Downgrades Revvity to Market Perform From Outperform, Adjusts Price Target to $130 From $145

No time to waste: Revvity CFO Max Krakowiak

CFO.com

13 days ago

No time to waste: Revvity CFO Max Krakowiak

MT Newswires

20 days ago

Evercore ISI Adjusts Price Target on Revvity to $125 From $134

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Zacks

22 days ago

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Argus Research

a month ago

RVTY: Lowering target price to $118.00

Argus Research

a month ago

RVTY: Lowering target price to $120.00

Revvity to Present at J.P. Morgan Healthcare Conference

Business Wire

a month ago

Revvity to Present at J.P. Morgan Healthcare Conference

Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst

Benzinga

a month ago

Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst

MT Newswires

a month ago

BofA Securities Upgrades Revvity to Buy From Neutral

Argus Research

a month ago

RVTY: Raising target price to $124.00

Can Revvity, Inc. (NYSE:RVTY) Performance Keep Up Given Its Mixed Bag Of Fundamentals?

Simply Wall St.

a month ago

Can Revvity, Inc. (NYSE:RVTY) Performance Keep Up Given Its Mixed Bag Of Fundamentals?

Why Is Revvity (RVTY) Down 8.7% Since Last Earnings Report?

Zacks

2 months ago

Why Is Revvity (RVTY) Down 8.7% Since Last Earnings Report?

Argus Research

2 months ago

RVTY: What does Argus have to say about RVTY?

Argus Research

2 months ago

RVTY: Raising target price to $121.00

Revvity price target lowered to $135 from $140 at Barclays

TipRanks

2 months ago

Revvity price target lowered to $135 from $140 at Barclays

MT Newswires

2 months ago

Barclays Adjusts Price Target on Revvity to $135 From $140, Keeps Overweight Rating

Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK

Business Wire

2 months ago

Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK

Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells

Business Wire

2 months ago

Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells

Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference

Business Wire

2 months ago

Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference

Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation

Business Wire

2 months ago

Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation

We Think Revvity's (NYSE:RVTY) Healthy Earnings Might Be Conservative

Simply Wall St.

2 months ago

We Think Revvity's (NYSE:RVTY) Healthy Earnings Might Be Conservative

Argus Research

2 months ago

RVTY: Lowering target price to $126.00

Argus Research

3 months ago

RVTY: Raising target price to $132.00

MT Newswires

3 months ago

UBS Raises Revvity Price Target to $145 From $140, Maintains Neutral Rating

MT Newswires

3 months ago

Baird Adjusts Price Target on Revvity to $138 From $136, Maintains Outperform Rating

MT Newswires

3 months ago

TD Cowen Adjusts Price Target on Revvity to $144 From $141, Maintains Buy Rating

MT Newswires

3 months ago

Bernstein Adjusts Price Target on Revvity to $145 From $150, Maintains Outperform Rating

MT Newswires

3 months ago

Raymond James Adjusts Price Target on Revvity to $146 From $144, Maintains Outperform Rating

Revvity Third Quarter 2024 Earnings: EPS Beats Expectations

Simply Wall St.

3 months ago

Revvity Third Quarter 2024 Earnings: EPS Beats Expectations

Revvity Inc (RVTY) Q3 2024 Earnings Call Highlights: Strong EPS and Cash Flow Amid Market Challenges

GuruFocus.com

3 months ago

Revvity Inc (RVTY) Q3 2024 Earnings Call Highlights: Strong EPS and Cash Flow Amid Market Challenges

Thomson Reuters StreetEvents

3 months ago

Q3 2024 Revvity Inc Earnings Call

MT Newswires

3 months ago

Goldman Sachs Raises Price Target on Revvity to $140 From $130

RVTY Q3 Earnings & Revenues Beat Estimates, Guidance Revised

Zacks

3 months ago

RVTY Q3 Earnings & Revenues Beat Estimates, Guidance Revised

Morningstar Research

3 months ago

Analyst Report: Revvity, Inc.

MT Newswires

3 months ago

Evercore ISI Adjusts Price Target on Revvity to $134 From $132

MT Newswires

3 months ago

Update: Revvity Shares Rise After Higher Q3 Results; 2024 Adjusted Earnings Guidance Lifted

Here's What Key Metrics Tell Us About Revvity (RVTY) Q3 Earnings

Zacks

3 months ago

Here's What Key Metrics Tell Us About Revvity (RVTY) Q3 Earnings

Revvity (RVTY) Surpasses Q3 Earnings and Revenue Estimates

Zacks

3 months ago

Revvity (RVTY) Surpasses Q3 Earnings and Revenue Estimates

MT Newswires

3 months ago

Revvity's Q3 Adjusted Earnings, Revenue Rise; Updates 2024 Outlook

Associated Press Finance

3 months ago

Revvity: Q3 Earnings Snapshot

Revvity Announces Financial Results for the Third Quarter of 2024

Business Wire

3 months ago

Revvity Announces Financial Results for the Third Quarter of 2024

Revvity to Report Q3 Earnings: What's in Store for the Stock?

Zacks

3 months ago

Revvity to Report Q3 Earnings: What's in Store for the Stock?

MultiPlan Corporation (MPLN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

3 months ago

MultiPlan Corporation (MPLN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Earnings Preview: Revvity (RVTY) Q3 Earnings Expected to Decline

Zacks

3 months ago

Earnings Preview: Revvity (RVTY) Q3 Earnings Expected to Decline

Calculating The Fair Value Of Revvity, Inc. (NYSE:RVTY)

Simply Wall St.

3 months ago

Calculating The Fair Value Of Revvity, Inc. (NYSE:RVTY)

Revvity Board Declares Quarterly Dividend

Business Wire

3 months ago

Revvity Board Declares Quarterly Dividend

Revvity Shares Decline Despite Launch of Transcribe AI Solution

Zacks

3 months ago

Revvity Shares Decline Despite Launch of Transcribe AI Solution

Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories

Business Wire

3 months ago

Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories

Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report

Business Wire

3 months ago

Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report

MT Newswires

3 months ago

Leerink Adjusts Price Target on Revvity to $135 From $130

MT Newswires

3 months ago

Bernstein Adjusts Revvity Price Target to $150 From $145, Maintains Outperform Rating

MT Newswires

3 months ago

Barclays Upgrades Revvity to Overweight, Price Target is $140

Revvity Ramps Up R&D Spending Since PerkinElmer Split

The Wall Street Journal

3 months ago

Revvity Ramps Up R&D Spending Since PerkinElmer Split

QIAGEN's TB Testing Business Gets New Exposure at Global Summit

Zacks

3 months ago

QIAGEN's TB Testing Business Gets New Exposure at Global Summit

RVTY's Latest Launch to Enable APOE Genotyping of Alzheimer's Disease

Zacks

3 months ago

RVTY's Latest Launch to Enable APOE Genotyping of Alzheimer's Disease

Bionano Genomics Inc (BNGO) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ...

GuruFocus.com

3 months ago

Bionano Genomics Inc (BNGO) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ...

Argus Research

3 months ago

RVTY: Lowering target price to $128.00

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Zacks

3 months ago

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

Investing in Revvity (NYSE:RVTY) five years ago would have delivered you a 53% gain

Simply Wall St.

3 months ago

Investing in Revvity (NYSE:RVTY) five years ago would have delivered you a 53% gain

Revvity To Hold Earnings Call on Monday, November 4, 2024

Business Wire

3 months ago

Revvity To Hold Earnings Call on Monday, November 4, 2024

MT Newswires

4 months ago

Revvity Launches APOE Genotyping Test in Europe

Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE Gene

Business Wire

4 months ago

Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE Gene

Is Revvity, Inc. (NYSE:RVTY) Potentially Undervalued?

Simply Wall St.

4 months ago

Is Revvity, Inc. (NYSE:RVTY) Potentially Undervalued?

Reasons to Retain Revvity Stock in Your Portfolio for Now

Zacks

5 months ago

Reasons to Retain Revvity Stock in Your Portfolio for Now

MT Newswires

5 months ago

Wells Fargo Initiates Revvity at Equalweight With $130 Price Target

Argus Research

5 months ago

RVTY: Raising target price to $98.00

MD or RVTY: Which Is the Better Value Stock Right Now?

Zacks

5 months ago

MD or RVTY: Which Is the Better Value Stock Right Now?

Revvity to Present at Upcoming Investor Conferences

Business Wire

5 months ago

Revvity to Present at Upcoming Investor Conferences

Argus Research

5 months ago

RVTY: Raising target price to $96.00

Some Investors May Be Willing To Look Past Revvity's (NYSE:RVTY) Soft Earnings

Simply Wall St.

5 months ago

Some Investors May Be Willing To Look Past Revvity's (NYSE:RVTY) Soft Earnings

MD or RVTY: Which Is the Better Value Stock Right Now?

Zacks

5 months ago

MD or RVTY: Which Is the Better Value Stock Right Now?

Decoding Revvity Inc (RVTY): A Strategic SWOT Insight

GuruFocus.com

5 months ago

Decoding Revvity Inc (RVTY): A Strategic SWOT Insight

Bionano Genomics (BNGO) Q2 2024 Earnings Call Transcript

Motley Fool

5 months ago

Bionano Genomics (BNGO) Q2 2024 Earnings Call Transcript

Revvity Second Quarter 2024 Earnings: EPS Misses Expectations

Simply Wall St.

6 months ago

Revvity Second Quarter 2024 Earnings: EPS Misses Expectations

MT Newswires

6 months ago

UBS Adjusts Revvity Price Target to $140 From $120, Maintains Neutral Rating

Company News for Jul 30, 2024

Zacks

6 months ago

Company News for Jul 30, 2024

MT Newswires

6 months ago

Bernstein Adjusts Price Target on Revvity to $145 From $121

MT Newswires

6 months ago

Goldman Sachs Adjusts Price Target on Revvity to $130 From $120

MT Newswires

6 months ago

Citigroup Adjusts Price Target on Revvity to $145 From $135

MT Newswires

6 months ago

Raymond James Adjusts Price Target on Revvity to $144 From $127

MT Newswires

6 months ago

Leerink Partners Adjusts Price Target on Revvity to $130 From $125

MT Newswires

6 months ago

Baird Adjusts Price Target on Revvity to $136 From $127

Thomson Reuters StreetEvents

6 months ago

Q2 2024 Revvity Inc Earnings Call

Morningstar Research

6 months ago

Analyst Report: Revvity, Inc.

MT Newswires

6 months ago

KeyBanc Raises Price Target on Revvity to $132 From $126

Revvity (RVTY) Q2 Earnings Beat Estimates, Guidance Revised

Zacks

6 months ago

Revvity (RVTY) Q2 Earnings Beat Estimates, Guidance Revised

MT Newswires

6 months ago

Evercore ISI Adjusts Price Target on Revvity to $132 From $126

Morningstar Research

6 months ago

Analyst Report: Revvity, Inc.

Diagnostic Products Demand Boosts Profit and Sales at Revvity

Investopedia

6 months ago

Diagnostic Products Demand Boosts Profit and Sales at Revvity

Life Science Firm Revvity Lifts Annual Profit Forecast On Strong Q2 Performance

Benzinga

6 months ago

Life Science Firm Revvity Lifts Annual Profit Forecast On Strong Q2 Performance

MT Newswires

6 months ago

Nephron Adjusts Price Target on Revvity to $134 From $124

Revvity (RVTY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks

6 months ago

Revvity (RVTY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Revvity (RVTY) to Report Q2 Earnings: What's in the Cards?

Zacks

6 months ago

Revvity (RVTY) to Report Q2 Earnings: What's in the Cards?

Share on Social Networks: